Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
Date:9/30/2013

CRANBURY, N.J., Sept. 30, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its fourth quarter and fiscal year ended June 30, 2013. 

Fiscal Year and Recent Highlights

  • Bremelanotide development for Female Sexual Dysfunction (FSD):
  • Completed a successful Phase 2B clinical trial and productive end-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA)
  • Pivotal Phase 3 clinical trials anticipated to initiate patient dosing in the first quarter of calendar year 2014
  • Obesity Collaboration with AstraZeneca:
  • AstraZeneca is evaluating the program and next steps following discontinuation of further development of AZD2820
  • A number of collaboration compounds are in various stages of preclinical testing
  • Intellectual property developments:
  • Two United States patents issued in the melanocortin field in the fiscal year ended June 30, 2013
  • Palatin has advanced its bremelanotide, PL-3994, and new melanocortin peptide patent applications in countries outside the United States
  • Equity financing:
  • On July 3, 2012, Palatin closed on a $35.0 million private placement.  The offering consisted of the sale of 3,873,000 shares of common stock, Series A 2012 warrants to purchase 31,988,151 shares of common stock, and Series B 2012 warrants to purchase 35,488,380 shares of common stock 
  • Net proceeds to Palatin after deducting offering expenses were $34.4 million 
  • Fourth Quarter and Fiscal Year End 2013 Results
    Palatin reported a net loss of $4.7 million, or $(0.04) per basic and diluted share, for the quarter ended June 30, 2013, compared to a net loss of $5.3 million, or $(0.14) per basic and diluted sha
    '/>"/>

    SOURCE Palatin Technologies, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
    2. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
    3. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
    4. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
    5. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
    6. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
    7. CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage
    8. Drug Discovery Technologies, BCC Research
    9. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
    10. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
    11. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... MENLO PARK, Calif. , March 2, ... (OTCQX: DMPI) (DelMar and the Company), a company ... in new orphan drug indications, today announced that ... U.S. Patent and Trademark Office (USPTO) for patent ... to improve the therapeutic benefit of suboptimally administered ...
    (Date:3/2/2015)... 2, 2015 Edison Investment ... the initiation of full coverage of Abzena  ... Edison,s pharma & biotech analysts Christian Glennie ... Abzena offers a range of key ... and more effective biological products. Antitope (immunogenicity testing, ...
    (Date:3/2/2015)... March 2, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, today ... offering of common stock have exercised their option to ... at a price to the public of $11.50 per ... is expected to be $64.8 million, after deducting underwriting ...
    Breaking Medicine Technology:DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Edison Initiates Coverage on Abzena 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3
    ... Mass., July 30 Peptimmune, Inc. a ... of US Patent Number,7,381,790 (the ,790 patent) ... PI-2301 peptide copolymer for the treatment of ... a Phase Ib multiple-ascending dose,double-blind, placebo-controlled randomized ...
    ... Assay, Only,Automated Transplant Monitoring Test that Meets International Standards for ... ... 30 The ability of blood,tests to precisely measure very ... a significant difference in assuring long-term,viability and survival, according to ...
    Cached Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 2Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 3
    (Date:3/3/2015)... The Data 360 Conference on “Healthcare’s Big ... Dearborn, MI, on March 5, 2015. Norman T. Kutemperor, ... He is known internationally as “The Father of NoSQL” and ... earned due to years of R&D on NoSQL DBs, culminating ... 10 years ago. Subsequent developments in Big Data-related technologies (such ...
    (Date:3/3/2015)... The authors Tracey Webb and Richard Mowbray have always ... a good and healthy diet . In “ Crude ... created an ingenious book that shows readers how to prepare ... , “Crude Food” shows readers that, in modern society, people ... over processed refined foods , such as wheat, sugars ...
    (Date:3/3/2015)... Dr. Stephen Edgerton, a ... has achieved Accredited Member Status in the American ... this accomplishment after completing a rigorous credentialing process ... the submission of clinical cases for examination. ... up in Connecticut, Charlotte, North Carolina, Caracas, Venezuela ...
    (Date:3/3/2015)... 03, 2015 Aureus Medical Group (web: ... jobs, has announced that it will participate as an ... Tuesday, March 17, 2015 in St. Louis, MO. , ... meet job-seeking residents and fellows in a comfortable, relaxed ... will be available to speak with attendees about ...
    (Date:3/2/2015)... (PRWEB) March 02, 2015 Formetco today ... billboard design. The FTX uses state-of-the-art technology to ... performance reliability, and owner satisfaction. An item of ... the exclusive Formetco 10 year LED Brightness Warranty. , ... to be a superior billboard among any other billboard ...
    Breaking Medicine News(10 mins):Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:Formetco Launches Innovative LED Billboard System 2
    ... Arlington-based Equal Health,once again contributed generously to Santa,s Helpers, ... affiliate WFAA founded the annual event to help out,during ... economically,disadvantaged families. , On Wednesday, ... company,s donations to the television studio. "We,ve been,donating the ...
    ... National Cervical Health Awareness Month, Acting Secretary of Health Everette ... prevention and the need for pap tests. "Every January ... all Pennsylvanians to do what they can to improve their ... Cervical Cancer Month, I want to remind our mothers, sisters, ...
    ... at huge costs here in the United States , , ... costing the small Canadian province of Quebec, population 7 ... , No doubt, sleepless nights from Seattle to Tampa ... more. , Susan Zafarlotfi, clinical director of the Institute ...
    ... and flu at bay , , FRIDAY, Jan. 2 (HealthDay News) -- ... that doctors stand by as the best way to keep yourself ... is one of the simplest and most effective ways to keep ... experts say. , "Disease transmission is hand-to-hand combat, at least for ...
    ... Lewy bodies, clumps of aggregated proteins inside cells, ... disease and other neurodegenerative diseases. , The presence ... recycling and waste disposal, leading to the puzzle: ... , One possible answer: by breaking a survival ...
    ... the stereotypes of medical education from the student perspective: ... a novel Brandeis study published in Academic Medicine ... dominant environment of academic medicine from the perspective of ... , The study raises questions about how the ...
    Cached Medicine News:Health News:Santa Gets a Little Help from Equal Health 2Health News:Department of Health Recognizes January As Cervical Health Awareness Month 2Health News:Insomnia Costs Billions in Lost Productivity 2Health News:Insomnia Costs Billions in Lost Productivity 3Health News:To Protect Yourself, Wash Those Germs Away 2Health News:To Protect Yourself, Wash Those Germs Away 3Health News:To Protect Yourself, Wash Those Germs Away 4Health News:Toxicity mechanism identified for Parkinson's disease 2Health News:The culture of medicine 2
    ... natural anatomy of the eyelid for ... inserter/dilator instrument for ease of insertion. ... plugs feature the unique slanted collarette ... the eyelid. The slightly larger bulb ...
    Ellipsoid tip probe with sufficient rigidity to go through stenosis, yet round, pointed & flexible enough to avoid creating false passage....
    For canalicular laceration involving external 2/3 of one canaliculus. Medical grade silicone. Box of 3, sterile. Note: For safe and proper insertion of the punctum plug above, we recommend the use of...
    For Canalicular Stenosis. Non-traumatic tip. Silicone tubing swaged into probe. Note: Tubing securely swaged into malleable stainless steel probes. Medical grade silicone. Box of 3, sterile....
    Medicine Products: